Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitroAlejandro Ibáñez‐Costa, Justo P. Castaño, Esther Rivero‐Cortés et al.|Journal of Endocrinology|2016Cited by 74
In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive featuresAlejandro Ibáñez‐Costa, Raúl M. Luque, Manuel D. Gahete et al.|Scientific Reports|2015Cited by 60
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea‐Agulla, Raúl M. Luque, Enrique Gómez‐Gómez et al.|Molecular Cancer|2017Cited by 51
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarkerDaniel Hormaechea‐Agulla, Raúl M. Luque, Enrique Gómez‐Gómez et al.|Cancer Letters|2016Cited by 38
In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parametersRaúl M. Luque, Mónica Marazuela, Miguel Sampedro‐Núñez et al.|Oncotarget|2015Cited by 35